Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 18291258)

Published in Surgery on December 21, 2007

Authors

Manousos M Konstadoulakis1, Sasan Roayaie, Ilias P Gomatos, Daniel Labow, Maria-Isabell Fiel, Charles M Miller, Myron E Schwartz

Author Affiliations

1: Recanati-Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY, USA. manousos.konstadoulakis@mountsinai.org

Articles citing this

Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today (2011) 1.29

Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol (2009) 1.00

Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am (2014) 0.95

Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94

Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver (2016) 0.89

Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management. Gastroenterol Res Pract (2015) 0.87

Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. Ann Surg Oncol (2014) 0.84

Surgical management of proximal bile duct cancers. Langenbecks Arch Surg (2012) 0.83

Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. HPB (Oxford) (2014) 0.82

Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma. Chin J Cancer Res (2011) 0.81

In-hospital mortality after resection of biliary tract cancer in the United States. HPB (Oxford) (2010) 0.80

DNA index is a strong predictive marker in intrahepatic cholangiocarcinoma: the results of a five-year prospective study. Surg Today (2013) 0.79

Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma. Hepatology (2012) 0.77

Preliminary experience with CT-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma. HPB (Oxford) (2012) 0.77

Intraoperative injuries during liver resection: analysis of 1,005 procedures. Hepatol Int (2011) 0.77

A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype. Dig Dis Sci (2013) 0.76

Liver resection for intrahepatic cholangiocellular carcinoma: when is it worthwhile? World J Surg (2008) 0.75

Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr (2017) 0.75

Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma. World J Surg (2014) 0.75

Pancreatic recurrence of intrahepatic cholangiocarcinoma: Case report and review of the literature. World J Gastrointest Surg (2014) 0.75

Is it possible to define early distal cholangiocarcinoma? Langenbecks Arch Surg (2015) 0.75

Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol (2017) 0.75

Articles by these authors

Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med (2008) 9.20

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93

The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33

Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology (2013) 5.05

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35

Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology (2008) 4.03

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology (2007) 3.85

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology (2011) 2.66

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol (2009) 2.42

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42

Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology (2006) 2.32

Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol (2008) 2.22

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg (2002) 2.14

Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol (2007) 1.95

A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology (2009) 1.90

Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl (2004) 1.88

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology (2011) 1.77

Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg (2012) 1.70

Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation (2004) 1.57

Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg (2015) 1.53

Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique. Liver Transpl (2009) 1.51

Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50

Outcomes of simultaneous liver transplantation and elective cardiac surgical procedures. Ann Thorac Surg (2011) 1.49

Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol (2007) 1.49

Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46

Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int (2010) 1.46

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44

Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36

Anatomic variations in right liver living donors. J Am Coll Surg (2004) 1.33

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer (2009) 1.28

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol (2008) 1.26

Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on "Surgical Misinterpretation" of the BCLC Staging System. Ann Surg (2015) 1.17

Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant (2004) 1.17

Quality of life after lobectomy for adult liver transplantation. Transplantation (2002) 1.15

Feasibility and preliminary accuracy of high-resolution imaging of the liver and pancreas using FNA compatible microendoscopy (with video). Gastrointest Endosc (2012) 1.09

Perioperative blood transfusion and long-term outcomes after resection of hilar cholangiocarcinoma. J Gastrointest Surg (2015) 1.07

Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg (2002) 1.03

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl (2009) 1.02

Two-trocar laparoscopic-assisted appendectomy versus conventional laparoscopic appendectomy in patients with acute appendicitis. J Laparoendosc Adv Surg Tech A (2006) 1.02

Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg (2008) 1.02

Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol (2010) 1.00

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg (2014) 0.99

Live donor liver transplantation. Liver Transpl (2006) 0.99

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol (2005) 0.97

Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl (2004) 0.96

Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg (2002) 0.94

Liver transplantation for neuroendocrine tumors. J Gastrointest Surg (2004) 0.93

Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement. Ann Surg Oncol (2014) 0.92

Use of a branch patch with the cystic artery in living-related liver transplantation. Clin Transplant (2004) 0.91

Clinical implications of sleeve gastrectomy as a source of spleen infarction or ischemia. Obes Surg (2011) 0.91

Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis (2011) 0.91

Post-traumatic pseudoaneurysm of the common hepatic artery with duodenal fistula. HPB (Oxford) (2002) 0.91

Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor? Liver Transpl (2005) 0.90

Resection of large hepatocellular carcinoma (≥10 cm): a unique western perspective. J Surg Oncol (2012) 0.90

Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol (2008) 0.90

"Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphon. Liver Transpl (2008) 0.89

Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis. Semin Liver Dis (2008) 0.88

Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation. Hepatology (2015) 0.88

Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review. Pediatr Transplant (2015) 0.88

Resection of hepatocellular carcinoma without cirrhosis. Ann Surg (2012) 0.87

Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma. J Surg Oncol (2008) 0.86

Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdom Imaging (2011) 0.86

BRCA2 gene mutations in Greek patients with familial breast cancer. Hum Mutat (2002) 0.86

Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol (2008) 0.86

Retracted Liver functional reserve estimation: state of the art and relevance to local treatments. Oncology (2010) 0.86

Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma--a case report. Liver Transpl (2006) 0.86

Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly. Surg Oncol (2013) 0.86

Prospective appraisal of a 2-day training course on laparoscopic sleeve gastrectomy: the ELTC experience. Surg Endosc (2010) 0.85

Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl (2011) 0.85

Giant hemangioma of the adrenal. Isr Med Assoc J (2004) 0.85

Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB (Oxford) (2013) 0.84